OncoCyte (OCX) Misses Q3 EPS by 98c
Tweet
Share
E-mailGet Alerts OCX Hot Sheet
Join SI Premium – FREE
OncoCyte (NASDAQ: OCX) reported Q3 EPS of ($0.98). Revenue for the quarter came in at $110 thousand.
For earnings history and earnings-related data on OncoCyte (OCX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Evercore ISI Starts Credo Tech (CRDO) at Outperform
- John Swann of SPX Technologies to retire in January 2027
- SpaceX (SPCX) call put ratio 1 call to 1 put on 1.9M contracts
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
